Kyphon spends $12.25 million to expand patent portfolio
This article was originally published in Clinica
Executive Summary
Kyphon, which has seen its first-half 2002 revenues from its balloon technology for orthopaedic applications more than double to $33m, is spending $12.25m to broaden its patent portfolio. The company has formed a sublicensing agreement with Bonutti Research Inc, gaining access to 23 US patents, which were issued to founder Dr Peter Bonutti.